About the Authors

Eamonn Gormley

egormley@ucd.ie

Affiliation School of Veterinary Medicine, University College Dublin (UCD), Dublin, Ireland

Deirdre Ní Bhuachalla

Affiliation School of Veterinary Medicine, University College Dublin (UCD), Dublin, Ireland

James O’Keeffe

Affiliation Dept of Agriculture, Food and the Marine, Head of Wildlife Unit, Agriculture House, Dublin, Ireland

Denise Murphy

Affiliation School of Veterinary Medicine, University College Dublin (UCD), Dublin, Ireland

Frank E. Aldwell

Affiliation Immune Solutions Ltd, Centre for Innovation, University of Otago, Dunedin, New Zealand

Tara Fitzsimons

Affiliation School of Veterinary Medicine, University College Dublin (UCD), Dublin, Ireland

Paul Stanley

Affiliation School of Veterinary Medicine, University College Dublin (UCD), Dublin, Ireland

Jamie A. Tratalos

Affiliation UCD Centre for Veterinary Epidemiology and Risk Analysis (CVERA), School of Veterinary Medicine, University College Dublin (UCD), Dublin, Ireland

Guy McGrath

Affiliation UCD Centre for Veterinary Epidemiology and Risk Analysis (CVERA), School of Veterinary Medicine, University College Dublin (UCD), Dublin, Ireland

Naomi Fogarty

Affiliation Central Veterinary Research Laboratory, Backweston, Co. Kildare, Ireland

Kevin Kenny

Affiliation Central Veterinary Research Laboratory, Backweston, Co. Kildare, Ireland

Simon J. More

Affiliation UCD Centre for Veterinary Epidemiology and Risk Analysis (CVERA), School of Veterinary Medicine, University College Dublin (UCD), Dublin, Ireland

Locksley L. McV. Messam

Affiliation School of Veterinary Medicine, University College Dublin (UCD), Dublin, Ireland

Leigh A. L. Corner

Affiliation School of Veterinary Medicine, University College Dublin (UCD), Dublin, Ireland

Competing Interests

FEA is an Inventor on a patent related to the Liporale technology and is a Director on a company (Immune Solutions Ltd) which has a vested interest in commercializing Liporale as an oral delivery platform. Liporale is covered by the following pending patents and applications: “Antigenic Compositions” WIPO WO/2003/009868, PCT/NZ2002/00132, NZ 546141, AU 2002/326233, US 2004/0234533, EP 02760915.5, CA 2454920, ZA 2004/1211, CN 02817408.9, IN 00302/DELNP/2004, JP 2003-515260, HK 04109263.7. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceptualization: EG DM LALC. Data curation: DNB PS JAT. Formal analysis: EG LLMcVM. Investigation: EG DNB DM TF NF KK LALC. Methodology: GMcG LLMcVM. Project administration: EG LALC JO'K. Resources: NF KK. Software: GMcG. Supervision: EG LALC JO'K. Writing – original draft: EG LALC LLMcVM. Writing – review & editing: EG DNB SJM LLMcVM KK FEA LALC.